NHS Devon

Search help

Quality, Effectiveness, Openness, Improvement, Respect

What treatments NHS Devon does and does not routinely fund - Overarching Policies

Click the links below for the documents that are available on line.

Next to each Policy, in brackets, is the associated Equality Impact Assessment if currently available.

  • Fast Access to Modern Treatment Policy - TP01
  • Low Priority Treatments Policy - TP02 (and EIA - February 2011)
    • GP guidance notes SW Devon version - TP02A
    • Patient guidance notes SW Devon - TP02B
  • Off Licence Drugs Policy for Exceptional Treatments Panel - TP03
  • Provision of NHS Funded IVF - TP04
  • Commissioning NICE TAGs - TP05
  • Working with the Pharmaceutical Industry - TP06 (to follow)
  • Business Conduct Policy - HR 06
  • Implementation of NICE Guidance Policy - TP07
  • Treatment Decisions Appeals Panel Process - TP08
  • Planned Treatment Abroad - TP10
  • Guidance Note - Access to NHS Funding Following Third Party Funded Treatment - TP11
  • Guidance Note - The Role of Commissioners in the Evaluation of Individual Treatments and the Funding of Clinical Research - TP12
  • Ongoing Access to Treatment Following the Ending of Industry Sponsored Clinical Trials or Funding - TP13 & Equality Impact Assessment TP13
  • Ongoing Access to Treatment Following Completion of Non-commercially Funded Trials - TP14 & Equality Impact Assessment TP14
  • Ongoing Access to Treatment Following Completion of NHS Commissioner-funded Trials - TP15 & Equality Impact Assessment TP15
  • Defining the Boundaries between NHS and Private Healthcare - TP16 & Equality Impact Assessment TP16
  • Experimental and Unproven Treatments - TP17 & Equality Impact Assessment TP17
  • Ongoing Access to Treatment following a “Trial of Treatment” which has not been Sanctioned, Routinely Funded or Formally Assessed and Prioritised by the Primary Care Trust - TP18 & Equality Impact Assessment TP18

Click the link to view or download the form How to make an application for funding exceptional treatments.